Literature DB >> 25339768

Uneven genetic robustness of HIV-1 integrase.

Suzannah J Rihn1, Joseph Hughes2, Sam J Wilson2, Paul D Bieniasz3.   

Abstract

UNLABELLED: Genetic robustness (tolerance of mutation) may be a naturally selected property in some viruses, because it should enhance adaptability. Robustness should be especially beneficial to viruses like HIV-1 that exhibit high mutation rates and exist in immunologically hostile environments. Surprisingly, however, the HIV-1 capsid protein (CA) exhibits extreme fragility. To determine whether fragility is a general property of HIV-1 proteins, we created a large library of random, single-amino-acid mutants in HIV-1 integrase (IN), covering >40% of amino acid positions. Despite similar degrees of sequence variation in naturally occurring IN and CA sequences, we found that HIV-1 IN was significantly more robust than CA, with random nonsilent IN mutations only half as likely to cause lethal defects. Interestingly, IN and CA were similar in that a subset of mutations with high in vitro fitness were rare in natural populations. IN mutations of this type were more likely to occur in the buried interior of the modeled HIV-1 intasome, suggesting that even very subtle fitness effects suppress variation in natural HIV-1 populations. Lethal mutations, in particular those that perturbed particle production, proteolytic processing, and particle-associated IN levels, were strikingly localized at specific IN subunit interfaces. This observation strongly suggests that binding interactions between particular IN subunits regulate proteolysis during HIV-1 virion morphogenesis. Overall, use of the IN mutant library in conjunction with structural models demonstrates the overall robustness of IN and highlights particular regions of vulnerability that may be targeted in therapeutic interventions. IMPORTANCE: The HIV-1 integrase (IN) protein is responsible for the integration of the viral genome into the host cell chromosome. To measure the capacity of IN to maintain function in the face of mutation, and to probe structure/function relationships, we created a library of random single-amino-acid IN mutations that could mimic the types of mutations that naturally occur during HIV-1 infection. Previously, we measured the robustness of HIV-1 capsid in this manner and determined that it is extremely intolerant of mutation. In contrast to CA, HIV-1 IN proved relatively robust, with far fewer mutations causing lethal defects. However, when we subsequently mapped the lethal mutations onto a model of the structure of the multisubunit IN-viral DNA complex, we found the lethal mutations that caused virus morphogenesis defects tended to be highly localized at subunit interfaces. This discovery of vulnerable regions of HIV-1 IN could inform development of novel therapeutics.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25339768      PMCID: PMC4301135          DOI: 10.1128/JVI.02451-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  91 in total

1.  Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases.

Authors:  J Kulkosky; K S Jones; R A Katz; J P Mack; A M Skalka
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

Review 2.  Interplay between RNA structure and protein evolution in HIV-1.

Authors:  Rafael Sanjuán; Antonio V Bordería
Journal:  Mol Biol Evol       Date:  2010-12-06       Impact factor: 16.240

3.  Four-tiered pi interaction at the dimeric interface of HIV-1 integrase critical for DNA integration and viral infectivity.

Authors:  Laith Q Al-Mawsawi; Anneleen Hombrouck; Raveendra Dayam; Zeger Debyser; Nouri Neamati
Journal:  Virology       Date:  2008-06-02       Impact factor: 3.616

4.  Integration requires a specific interaction of the donor DNA terminal 5'-cytosine with glutamine 148 of the HIV-1 integrase flexible loop.

Authors:  Allison A Johnson; Webster Santos; Godwin C G Pais; Christophe Marchand; Ronak Amin; Terrence R Burke; Gregory Verdine; Yves Pommier
Journal:  J Biol Chem       Date:  2005-10-27       Impact factor: 5.157

5.  Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases.

Authors:  F Dyda; A B Hickman; T M Jenkins; A Engelman; R Craigie; D R Davies
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

6.  Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking.

Authors:  T M Jenkins; D Esposito; A Engelman; R Craigie
Journal:  EMBO J       Date:  1997-11-17       Impact factor: 11.598

7.  Identification and characterization of a temperature-sensitive mutant of human immunodeficiency virus type 1 by alanine scanning mutagenesis of the integrase gene.

Authors:  M Wiskerchen; M A Muesing
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

8.  LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells.

Authors:  Goedele Maertens; Peter Cherepanov; Wim Pluymers; Katrien Busschots; Erik De Clercq; Zeger Debyser; Yves Engelborghs
Journal:  J Biol Chem       Date:  2003-06-09       Impact factor: 5.157

9.  Selection for robustness in mutagenized RNA viruses.

Authors:  Rafael Sanjuán; José M Cuevas; Victoria Furió; Edward C Holmes; Andrés Moya
Journal:  PLoS Genet       Date:  2007-04-20       Impact factor: 5.917

10.  On the role of four small hairpins in the HIV-1 RNA genome.

Authors:  Stefanie A Knoepfel; Ben Berkhout
Journal:  RNA Biol       Date:  2013-03-27       Impact factor: 4.652

View more
  16 in total

1.  A CRISPR/Cas9 library to map the HIV-1 provirus genetic fitness.

Authors:  K E Yoder
Journal:  Acta Virol       Date:  2019       Impact factor: 1.162

2.  Cryo-EM structures and atomic model of the HIV-1 strand transfer complex intasome.

Authors:  Dario Oliveira Passos; Min Li; Renbin Yang; Stephanie V Rebensburg; Rodolfo Ghirlando; Youngmin Jeon; Nikoloz Shkriabai; Mamuka Kvaratskhelia; Robert Craigie; Dmitry Lyumkis
Journal:  Science       Date:  2017-01-06       Impact factor: 47.728

3.  HIV-1 Integrase Binds the Viral RNA Genome and Is Essential during Virion Morphogenesis.

Authors:  Jacques J Kessl; Sebla B Kutluay; Dana Townsend; Stephanie Rebensburg; Alison Slaughter; Ross C Larue; Nikoloz Shkriabai; Nordine Bakouche; James R Fuchs; Paul D Bieniasz; Mamuka Kvaratskhelia
Journal:  Cell       Date:  2016-08-25       Impact factor: 41.582

4.  Vulnerable targets in HIV-1 Pol for attenuation-based vaccine design.

Authors:  Doty B A Ojwach; Paradise Madlala; Michelle Gordon; Thumbi Ndung'u; Jaclyn K Mann
Journal:  Virology       Date:  2020-12-10       Impact factor: 3.616

5.  The KT Jeang Retrovirology prize 2015: Paul Bieniasz.

Authors: 
Journal:  Retrovirology       Date:  2015-10-05       Impact factor: 4.602

6.  Extremely High Mutation Rate of HIV-1 In Vivo.

Authors:  José M Cuevas; Ron Geller; Raquel Garijo; José López-Aldeguer; Rafael Sanjuán
Journal:  PLoS Biol       Date:  2015-09-16       Impact factor: 8.029

7.  Epistasis as a determinant of the HIV-1 protease's robustness to mutation.

Authors:  Elena Capel; Mariona Parera; Miguel Angel Martinez
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

8.  A Highly Conserved Residue in HIV-1 Nef Alpha Helix 2 Modulates Protein Expression.

Authors:  Aaron L Johnson; Brennan S Dirk; Mathieu Coutu; S M Mansour Haeryfar; Eric J Arts; Andrés Finzi; Jimmy D Dikeakos
Journal:  mSphere       Date:  2016-11-09       Impact factor: 4.389

9.  The Envelope Gene of Transmitted HIV-1 Resists a Late Interferon Gamma-Induced Block.

Authors:  Suzannah J Rihn; Toshana L Foster; Idoia Busnadiego; Muhamad Afiq Aziz; Joseph Hughes; Stuart J D Neil; Sam J Wilson
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

10.  HIV-1 Protease, Reverse Transcriptase, and Integrase Variation.

Authors:  Soo-Yon Rhee; Kris Sankaran; Vici Varghese; Mark A Winters; Christopher B Hurt; Joseph J Eron; Neil Parkin; Susan P Holmes; Mark Holodniy; Robert W Shafer
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.